Agilent Acquires BioTek Instruments

Agilent Acquires BioTek Instruments

Agilent Technologies (NYSE: A) announced its largest deal ever in July 2019. The Santa Clara, California-based biotech purchased privately held BioTek Instruments for nearly $1.2 billion. Agilent provides bio-analytical solutions and services to the life sciences, diagnostics, and genomics, chemical analysis, communications and electronics industries worldwide. On a trailing 12-month basis it generated revenue of $5.0 billion, EBITDA of $1.2 billion and net income of $1.1 billion. BioTek designs, manufactures and distributes life science instrumentation worldwide. Its product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators and stackers.... Read More »